BSE Live
Jan 16, 09:53Prev. Close
172.45
Open Price
170.00
Bid Price (Qty.)
172.00 (46)
Offer Price (Qty.)
172.40 (45)
NSE Live
Jan 16, 09:53Prev. Close
172.45
Open Price
172.10
Bid Price (Qty.)
172.25 (25)
Offer Price (Qty.)
172.27 (17)
| Balance Sheet of Marksans Pharma (in Rs. Cr.) | Mar 05 | |
| 12 mths | ||
| EQUITIES AND LIABILITIES | ||
| SHAREHOLDER'S FUNDS | ||
| Equity Share Capital | 35.94 | |
| Total Share Capital | 49.44 | |
| Reserves and Surplus | 52.86 | |
| Total Reserves and Surplus | 52.86 | |
| Total Shareholders Funds | 102.31 | |
| Minority Interest | 0.00 | |
| NON-CURRENT LIABILITIES | ||
| Long Term Borrowings | 58.67 | |
| Deferred Tax Liabilities [Net] | 4.49 | |
| Other Long Term Liabilities | 0.00 | |
| Long Term Provisions | 0.00 | |
| Total Non-Current Liabilities | 63.15 | |
| CURRENT LIABILITIES | ||
| Short Term Borrowings | 31.09 | |
| Trade Payables | 36.48 | |
| Other Current Liabilities | 0.02 | |
| Short Term Provisions | 2.23 | |
| Total Current Liabilities | 69.81 | |
| Total Capital And Liabilities | 235.27 | |
| ASSETS | ||
| NON-CURRENT ASSETS | ||
| Tangible Assets | 101.66 | |
| Intangible Assets | 0.00 | |
| Capital Work-In-Progress | 0.00 | |
| Fixed Assets | 101.66 | |
| Non-Current Investments | 0.01 | |
| Deferred Tax Assets [Net] | 0.28 | |
| Long Term Loans And Advances | 0.00 | |
| Other Non-Current Assets | 2.16 | |
| Total Non-Current Assets | 104.11 | |
| CURRENT ASSETS | ||
| Current Investments | 0.00 | |
| Inventories | 52.42 | |
| Trade Receivables | 61.62 | |
| Cash And Cash Equivalents | 9.71 | |
| Short Term Loans And Advances | 7.42 | |
| OtherCurrentAssets | 0.00 | |
| Total Current Assets | 131.16 | |
| Total Assets | 235.27 | |
| OTHER ADDITIONAL INFORMATION | ||
| CONTINGENT LIABILITIES, COMMITMENTS | ||
| Contingent Liabilities | 0.41 | |
| BONUS DETAILS | ||
| Bonus Equity Share Capital | 0.00 | |
| NON-CURRENT INVESTMENTS | ||
| Non-Current Investments Quoted Market Value | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.01 | |
| CURRENT INVESTMENTS | ||
| Current Investments Quoted Market Value | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y